Non-Hodgkins Lymphoma (NHL)

Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment

Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders

Outcomes of Early and Late Administration G-CSF for Primary Prophylaxis in Non-Hodgkin's Lymphoma Patients

Study of XL114 in Subjects With Non-Hodgkin's Lymphoma

Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma

Zevalin Post-marketing Surveillance in Japan

Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients

Tumor Registry of Lymphatic Neoplasia

Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma

Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

Haploid Allogeneic Transplant Using the CliniMACS System

Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)

Zevalin Post-marketing Surveillance for Adequateness of Image Interpretation Criteria in Japan